Worcester, Massachusetts 01655

  • Diabetes Mellitus, Type 2


DM-BOOST uses clinical informatics tools to identify types of patients with gaps in diabetes care and deploy tailored, proactive outreach methods rooted in behavioral economics to nudge them towards increased engagement with diabetes self-management training and leverage patient-facing technologies to enhance longitudinal patient self-management support.

Study summary:

In DM-BOOST, the Principal investigator will deploy a mixed-methods, patient-centered approach to intervention development and initiate a multiphase optimization strategy (MOST) to learn how to maximize patient engagement and support of self-management training. In this pilot, study team will complete the first phase (Preparation), and initiate feasibility piloting of the second phase (Optimization). Completion of optimization and MOST's final phase (Evaluation), will occur in a subsequent project. In the preparation phase, Principal investigator will first analyze EHR and claims data in the UMCCTS data lake to identify sociodemographic characteristics associated with gaps in diabetes care to develop patient persona archetypes (Aim 1). Next, Principal investigator will selectively recruit patients of identified persona types as consultants, elicit stakeholder feedback during community engagement studios and conduct usability testing to iteratively design the intervention (Aim 2). Study team will then conduct a feasibility pilot (Aim 3) to assess user experience of the intervention implementation and collect exploratory outcome data to be used to inform a subsequent, complete optimization trial.


Inclusion Criteria: - Adults (age 18+) - Cognitively able to consent (Aims 2 and 3) - Diagnosed with type 2 diabetes (Aims 1-3) - Receive primary care at UMMHC in past 12 months at time of initial analysis (Aims 1-3) - English speaking (Aims 2 and 3) - Have access to patient portal or a smart phone (Aim 3) Exclusion Criteria: - Adults unable to consent (lacking cognitive capacity) (Aims 2 and 3) - Individuals who are not yet adults (infants, children, teenagers) (Aims 1-3) - Pregnant women (Aims 1-3) - Prisoners (Aims 1-3) - Non-English speaking (Aims 2 and 3)



Primary Contact:

Principal Investigator
Daniel J Amante, PhD, MPH
UMass Medical School

Daniel J Amante, PhD, MPH
Phone: 508-856-8480
Email: daniel.amante@umassmed.edu

Backup Contact:


Location Contact:

Worcester, Massachusetts 01655
United States

Daniel Amante, PhD
Phone: 774-418-3645
Email: Daniel.Amante@umassmed.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: June 20, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.